Eventide Healthcare Innovation Fund II launches indefinite offering in Boston
Eventide Asset Management is raising an indefinite private equity fund focused on healthcare innovation through its Delaware LP, targeting institutional investors with a $1M minimum. The fund filed under Regulation D exemptions 3(c)(7) and 506(c) and has not yet closed its first investment.
How this compares
- Across 494 private equity / buyout sponsors with more than one launch on EDGAR, the median gap between consecutive funds is 5 months.
- No earlier fund launch by this sponsor appears on EDGAR.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
People on the filing
| N/A Eventide Healthcare Innovation Fund II GP LLC | Promoter |
| N/A Eventide Asset Management, LLC | Promoter |
| Robin John | Executive Officer |
| Sean Mathew | Executive Officer |
| Finny Kuruvilla | Executive Officer |
| I-hung Shih | Executive Officer |
| Peter Luiso | Executive Officer |
| Jennifer Reiche | Executive Officer |
[email protected] · observed Work emails for the people on the filing, where the firm publishes or patterns them, labelled by confidence — subscribers
Signed by Sean Mathew, Chief Financial Officer of the Manager.
Placement agents / sales compensation: Jon Michael Schnackenberg; Matthew M McEathron; Stuart L Slack; Spencer Martin; Mark Wambolt
Why now — by persona
- Fund administrator:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Fund audit & tax:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Fund-formation counsel:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans.